← Back to Patent Explorer
US4764601A Expired / Lapsed US ⏱️ 0.0 years remaining

Composition for assaying cardiac glycosides from serum or plasma

Assignee: Ohio State University Research Foundation
•
Filing: 1985-10-18
•
Granted: 1988-08-16
•
Expires: 2005-10-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A fluorescent compound is made from the reaction of naphthoyl chloride and a cardiac glycoside derived from serum or plasma. The method of carrying out the reaction provides a product which allows for a 100-fold increase in sensitivity when the product is subjected to chromatographic analysis according to the described apparatus.

Inventors

  • 👤 Richard H. Reuning
  • 👤 James Hui
  • 👤 Theresa A. Shepard
  • 👤 Richard A. Sams

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 17:46
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/94; G01N33/9453; Y; Y10; Y10T; Y10T436/00; Y10T436/14; Y10T436/142222; Y10T436/143333; Y10T436/20; Y10T436/203332; Y10T436/25

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 78 words
A composition consisting essentially of: (i) a first fluorescent compound which includes a moiety of a cardiac glycoside from one of serum and plasma derivatized by a naphthoyl moiety from a naphthoyl chloride purified by fractional distillation; (ii) a second and different flourescent compound which includes a moiety of a known cardiac glycoside derivatized by a naphthoyl moiety from said naphthoyl chloride purified by fractional distillation; and (iii) a liquid mobile phase for said first and second compounds.
Claim 2
Dependent Claim 78 words
A composition consisting essentially of: (i) a first fluorescent compound which includes a moiety of a cardiac glycoside from one of serum and plasma derivatized by a naphthoyl moiety from a naphthoyl chloride purified by fractional distillation; (ii) a second and different flourescent compound which includes a moiety of a known cardiac glycoside derivatized by a naphthoyl moiety from said naphthoyl chloride purified by fractional distillation; and (iii) a liquid mobile phase for said first and second compounds.
Claim 3
Dependent Claim 19 words
The composition of claim 1 in which the liquid mobile phase consists essentially of hexane, methylene chloride and acetonitrile.
Claim 4
Dependent Claim 20 words
The composition of claim 2 wherein the hexane, methylene chloride and acetonitrile are present in a ratio of about 27:5:5.
Claim 5
Dependent Claim 18 words
The composition of claim 1 in which digoxin is said cardiac glycoside from one of serum or plasma.
Claim 6
Dependent Claim 27 words
The composition of claim 1 in which said cardiac glycoside from one of serum or plasma is digoxin and in which said known cardiac glycoside is digitoxin.
Claim 7
Dependent Claim 17 words
The composition of claim 5 in which said naphthoyl chloride purified by fractional distillation is 1-naphthoyl chloride.

References Cited (Backward Citations)

CA484578A Cited
CA488775A Cited
US4184037A Cited
US4555504A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-08-16 1992-02-15 1992-08-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-08-16 1996-02-15 1996-08-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-08-16 2000-02-15 2000-08-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag